The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway (Q40858871)
scientific article published on September 2000
Language:
(P31) (Q13442814)
(P304) 99-107
(P407) (Q1860)
(P433) 1
(P478) 131
(P577) Friday, September 1, 2000
(P1433) (Q919631)
(P1476) "The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway" (language: en)
(P2093) K U Birkenkamp
L M Tuyt
C Lummen
A T Wierenga
W Kruijer
E Vellenga
(P2860) (Q33995645)
(Q34743658)
(Q28252726)
(Q28611453)
(Q30452676)
(Q29618717)
(Q29614706)
(Q29614707)
(Q24650627)
(Q38322155)
(Q40757575)
(Q29620495)
(Q28508403)
(Q27860599)
(Q37876246)
(Q24564667)
(Q40943086)
(Q41006169)
(Q41050922)
(Q41062073)
(Q41016399)
(Q41105089)
(Q41688997)
(Q41639488)
(Q41545806)
(Q42609308)
(Q41526418)
(Q42815989)
(Q53406516)
(Q52192943)
(Q41565960)
(Q68828861)
(Q78069508)
(Q72618174)
(Q72350511)
(Q77320713)
(Q77733964)
other details
description scientific article published on September 2000

External Links